Los Angeles CA
11-11-2023 7:43pm

FDA Approves Zepbound for Weight Loss

The drug Zepbound was approved by the U.S. Food and Drug Administration on Wednesday to treat obesity. It is sold under the brand name Mounjaro as a diabetes drug and is manufactured by pharmaceutical company Eli Lilly and Co. 

By Staff

More News from Los Angeles
I'm interested
I disagree with this
This is unverified
Spam
Offensive